| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000157306.10 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036600116 |
Resistant |
| ENSG00000157306.10 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.021750991 |
Sensitive |
| ENSG00000157306.10 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.039214715 |
Sensitive |
